[TABLE OF CONTENTS]

1 INTRODUCTION OF GLOBAL AI IN MEDICAL IMAGING MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES

4 GLOBAL AI IN MEDICAL IMAGING MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS

5 GLOBAL AI IN MEDICAL IMAGING MARKET, BY AI TECHNOLOGY
5.1 OVERVIEW
5.2 DEEP LEARNING
5.3 NATURAL LANGUAGE PROCESSING (NLP)
5.4 OTHERS

6 GLOBAL AI IN MEDICAL IMAGING MARKET, BY SOLUTION
6.1 OVERVIEW
6.2 SOFTWARE TOOLS/ PLATFORM
6.3 SERVICES
6.3.1 INTEGRATION
6.3.2 DEPLOYMENT

7 GLOBAL AI IN MEDICAL IMAGING MARKET, BY MODALITY
7.1 OVERVIEW
7.2 CT SCAN
7.3 MRI
7.4 X-RAYS
7.5 ULTRASOUND IMAGING
7.6 NUCLEAR IMAGING 

8 GLOBAL AI IN MEDICAL IMAGING MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 DIGITAL PATHOLOGY
8.3 ONCOLOGY
8.4 CARDIOVASCULAR
8.5 NEUROLOGY
8.6 LUNG (RESPIRATORY SYSTEM)
8.7 BREAST (MAMMOGRAPHY)
8.8 LIVER (GI)
8.9 ORAL DIAGNOSTICS
8.10 OTHER

9 GLOBAL AI IN MEDICAL IMAGING MARKET, BY END USE
9.1 OVERVIEW
9.2 HOSPITAL AND HEALTHCARE PROVIDERS
9.3 PATIENTS
9.4 PHARMACEUTICALS AND BIOTECHNOLOGY COMPANIES
9.5 HEALTHCARE PAYERS
9.6 OTHERS 

10 GLOBAL AI IN MEDICAL IMAGING MARKET, BY GEOGRAPHY
10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 NORTH AMERICA MARKET SNAPSHOT
10.2.2 U.S.
10.2.3 CANADA
10.2.4 MEXICO

10.3 EUROPE

10.3.1 EUROPE MARKET SNAPSHOT
10.3.2 WESTERN EUROPE
10.3.2.1 THE UK
10.3.2.2 GERMANY
10.3.2.3 FRANCE
10.3.2.4 ITALY
10.3.2.5 SPAIN
10.3.2.6 REST OF WESTERN EUROPE
10.3.3 EASTERN EUROPE
10.3.3.1 POLAND
10.3.3.2 RUSSIA
10.3.3.3 REST OF EASTERN EUROPE

10.4 ASIA PACIFIC

10.4.1 ASIA PACIFIC MARKET SNAPSHOT
10.4.2 CHINA
10.4.3 JAPAN
10.4.4 INDIA
10.4.5 AUSTRALIA & NEW ZEALAND
10.4.6 ASEAN
10.4.7 REST OF ASIA PACIFIC

10.5 MIDDLE EAST & AFRICA

10.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
10.5.2 UAE
10.5.3 SAUDI ARABIA
10.5.4 SOUTH AFRICA
10.5.5 REST OF MEA

10.6 SOUTH AMERICA

10.6.1 SOUTH AMERICA MARKET SNAPSHOT
10.6.2 BRAZIL
10.6.3 ARGENTINA
10.6.4 REST OF SOUTH AMERICA

11 GLOBAL AI IN MEDICAL IMAGING MARKET COMPETITIVE LANDSCAPE

11.1 OVERVIEW
11.2 COMPANY MARKET RANKING
11.3 KEY DEVELOPMENT STRATEGIES

12 COMPANY PROFILES

12.1 SIEMENS HEALTHINEERS
12.1.1 OVERVIEW
12.1.2 FINANCIAL PERFORMANCE
12.1.3 PRODUCT OUTLOOK
12.1.4 KEY DEVELOPMENTS

12.2 GENERAL ELECTRIC
12.2.1 OVERVIEW
12.2.2 FINANCIAL PERFORMANCE
12.2.3 PRODUCT OUTLOOK
12.2.4 KEY DEVELOPMENTS

12.3 KONINKLIJKE PHILIPS
12.3.1 OVERVIEW
12.3.2 FINANCIAL PERFORMANCE
12.3.3 PRODUCT OUTLOOK
12.3.4 KEY DEVELOPMENTS

12.4 IBM
12.4.1 OVERVIEW
12.4.2 FINANCIAL PERFORMANCE
12.4.3 PRODUCT OUTLOOK
12.4.4 KEY DEVELOPMENTS

12.5 AGFA-GEVAERT GROUP/AGFA HEALTH CARE
12.5.1 OVERVIEW
12.5.2 FINANCIAL PERFORMANCE
12.5.3 PRODUCT OUTLOOK
12.5.4 KEY DEVELOPMENTS

12.6 ARTERYS
12.6.1 OVERVIEW
12.6.2 FINANCIAL PERFORMANCE
12.6.3 PRODUCT OUTLOOK
12.6.4 KEY DEVELOPMENTS

12.7 AZMED
12.7.1 OVERVIEW
12.7.2 FINANCIAL PERFORMANCE
12.7.3 PRODUCT OUTLOOK
12.7.4 KEY DEVELOPMENTS

12.8. CAPTION HEALTH
12.8.1 OVERVIEW
12.8.2 FINANCIAL PERFORMANCE
12.8.3 PRODUCT OUTLOOK
12.8.4 KEY DEVELOPMENTS

12.9 GLEAMER
12.9.1 OVERVIEW
12.9.2 FINANCIAL PERFORMANCE
12.9.3 PRODUCT OUTLOOK
12.9.4 KEY DEVELOPMENTS

12.10 BUTTERFLY NETWORK
12.10.1 OVERVIEW
12.10.2 FINANCIAL PERFORMANCE
12.10.3 PRODUCT OUTLOOK
12.10.4 KEY DEVELOPMENTS